Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C

BACKGROUND: Nearly 0.5% of Iranians are infected with HCV. Peginterferon-alpha-2a and Peginterferon-alpha-2b are the two available types of interferon for the treatment of hepatitis C. Comparing the results of these two treatments is still a challenge. OBJECTIVES: The aim of this study was to compar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepat Mon
Autors principals: Pouresmaeeli, Mahdiyar, Alavian, Seyed Moayed, Keshvari, Maryam, Salimi, Shima, Mehrnoush, Leila
Format: Artigo
Idioma:Inglês
Publicat: Kowsar 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4612773/
https://ncbi.nlm.nih.gov/pubmed/26504470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.30780
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars